Reference
Jian H, et al. Effective treatment of low-doses decitabine in myelodysplastic syndrome / myeloproliferative neoplasms with JAK2/V617F. Blood 130 (Suppl. 1): Dec 2017 [abstract] - China
Rights and permissions
About this article
Cite this article
Decitabine. Reactions Weekly 1695, 151 (2018). https://doi.org/10.1007/s40278-018-43978-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-43978-8